Baiocchi Gian Luca, Marrelli Daniele, Verlato Giuseppe, Morgagni Paolo, Giacopuzzi Simone, Coniglio Arianna, Marchet Alberto, Rosa Fausto, Capponi Michela Giulii, Di Leo Alberto, Saragoni Luca, Ansaloni Luca, Pacelli Fabio, Nitti Donato, D'Ugo Domenico, Roviello Franco, Tiberio Guido A M, Giulini Stefano M, De Manzoni Giovanni
Department of Clinical and Experimental Sciences, Surgical Clinic, Brescia University, Brescia, Italy,
Ann Surg Oncol. 2014 Jun;21(6):2005-11. doi: 10.1245/s10434-014-3534-8. Epub 2014 Feb 14.
The Italian Research Group for Gastric Cancer supports the practice of follow-up after radical surgery for gastric cancer.
This multicenter, retrospective study (1998-2009) included patients with T1-4N0-3M0 gastric cancer who had undergone D2 gastrectomy and lymphadenectomy, with at least 15 lymph nodes examined, and who had developed recurrent disease. Timing and site of recurrence were correlated to the actual scheduled follow-up timing and modalities.
From eight centers, 814 patients with recurrent cancer and over 1,754 (46.4 %) patients undergoing gastrectomy were investigated (median follow-up 31 months). The most frequent sites of recurrence were local/regional lymph nodes (35.4 %), liver (24.3 %), peritoneum (30.3 %), lung (10.4 %) and intraluminal (7.5 %). Ninety-four percent of the recurrences were diagnosed within 2 years and 98 % within 3 years. Thoracoabdominal computed tomography (CT) scan and (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (18-FDG-PET) detected more than 90 % of recurrences, abdominal ultrasound detected 70 % and tumor markers detected 40 %, while <10 % were identified by physical examination, chest X-ray, and upper gastrointestinal endoscopy. Twenty-six percent of patients with recurrence were treated, but only 3.2 % were treated with potentially radical intent.
Oncological follow-up after radical surgery for gastric cancer should be focused in the first 3 years, and based mainly on thoracoabdominal CT scan and 18-FDG-PET.
意大利胃癌研究小组支持胃癌根治性手术后进行随访的做法。
这项多中心回顾性研究(1998 - 2009年)纳入了T1 - 4N0 - 3M0期胃癌患者,这些患者接受了D2胃切除术和淋巴结清扫术,至少检查了15个淋巴结,且出现了复发性疾病。复发的时间和部位与实际安排的随访时间及方式相关。
来自八个中心的814例复发癌患者以及超过1754例(46.4%)接受胃切除术的患者接受了调查(中位随访时间31个月)。最常见的复发部位是局部/区域淋巴结(35.4%)、肝脏(24.3%)、腹膜(30.3%)、肺(10.4%)和腔内(7.5%)。94%的复发在2年内被诊断出,98%在3年内被诊断出。胸腹部计算机断层扫描(CT)和18F - 氟 - 2 - 脱氧 - D - 葡萄糖正电子发射断层扫描(18 - FDG - PET)检测到超过90%的复发,腹部超声检测到70%,肿瘤标志物检测到40%,而通过体格检查、胸部X线和上消化道内镜检查发现的复发不到10%。26%的复发患者接受了治疗,但只有3.2%的患者接受了可能根治性的治疗。
胃癌根治性手术后的肿瘤学随访应在前3年集中进行,主要基于胸腹部CT扫描和18 - FDG - PET。